[(25R)-Spirost-5-en-3β-yl]4-O-(6-deoxy-α-L-mannopyranosyl)-β-D-glucopyranoside - Names and Identifiers
[(25R)-Spirost-5-en-3β-yl]4-O-(6-deoxy-α-L-mannopyranosyl)-β-D-glucopyranoside - Physico-chemical Properties
Molecular Formula | C39H62O12
|
Molar Mass | 722.9 |
Storage Condition | 2-8℃ |
[(25R)-Spirost-5-en-3β-yl]4-O-(6-deoxy-α-L-mannopyranosyl)-β-D-glucopyranoside - Introduction
(25R)-3-(-) spirosta-5-ene, chemically known as ((25R)-3β-(-) spirosta-5-ene), is a plant secondary metabolite. The following is a description of its nature, use, preparation and safety information:
Nature:
(25R)-3β-(25R) spirosta-5-ene is a white crystalline powder with an odorless or slightly fragrant odor. It is soluble in water and ethanol and practically insoluble in ether and benzene.
Use:
(25R)-3β-(a) spirosta-5-ene is widely used in the field of pharmacy and health care products. It has a variety of biological activities, including antioxidant, anti-inflammatory, anti-tumor and anti-aging effects. Therefore, it is often used as an active ingredient of drugs, for example, for the treatment of cardiovascular diseases, diabetes, depression, etc. In addition,(25R)-3β-(25R) spirosta-5-ene is also used in cosmetics and skin care products, with moisturizing, anti-wrinkle and other effects.
Method:
(25R)-3β-(R) spirosta-5-ene are usually prepared by extraction from plants. First, the plant material containing the subglycoside B is processed and pulverized, and then the subglycoside B is extracted from the plant by a solvent extraction method. Finally, high purity (25R)-3β-(Sr) spirosta-5-ene was obtained by crystallization or purification techniques.
Safety Information:
(25R)-3β-spirosta-5-ene There are no reports of significant toxicity. However, if used in excess, it may cause some adverse reactions, so the appropriate dosage and method of use should be followed. In addition, the use of (25R)-3β-(¾) spirosta-5-ene should be used with caution or avoided for certain groups of people, such as pregnant women, lactating women, and children.
Last Update:2024-04-09 21:01:54